348 related articles for article (PubMed ID: 9475762)
1. The effect of finasteride on the risk of acute urinary retention and the need for surgical treatment among men with benign prostatic hyperplasia. Finasteride Long-Term Efficacy and Safety Study Group.
McConnell JD; Bruskewitz R; Walsh P; Andriole G; Lieber M; Holtgrewe HL; Albertsen P; Roehrborn CG; Nickel JC; Wang DZ; Taylor AM; Waldstreicher J
N Engl J Med; 1998 Feb; 338(9):557-63. PubMed ID: 9475762
[TBL] [Abstract][Full Text] [Related]
2. Finasteride for benign prostatic hyperplasia.
Tacklind J; Fink HA; Macdonald R; Rutks I; Wilt TJ
Cochrane Database Syst Rev; 2010 Oct; 2010(10):CD006015. PubMed ID: 20927745
[TBL] [Abstract][Full Text] [Related]
3. Finasteride reduces the risk of incident clinical benign prostatic hyperplasia.
Parsons JK; Schenk JM; Arnold KB; Messer K; Till C; Thompson IM; Kristal AR; ;
Eur Urol; 2012 Aug; 62(2):234-41. PubMed ID: 22459892
[TBL] [Abstract][Full Text] [Related]
4. Prostate Transition Zone Fibrosis is Associated with Clinical Progression in the MTOPS Study.
Macoska JA; Uchtmann KS; Leverson GE; McVary KT; Ricke WA
J Urol; 2019 Dec; 202(6):1240-1247. PubMed ID: 31188728
[TBL] [Abstract][Full Text] [Related]
5. [Long-term effect of finasteride on high-risk patients with benign prostatic hyperplasia after implantation of thermo-expandable spiral prostatic stent].
Yi XM; He HW; Xu S; Zeng T; Han DH; Zhou WQ; Ge JP; Xue S
Zhonghua Nan Ke Xue; 2022 Dec; 28(12):1065-1070. PubMed ID: 37846625
[TBL] [Abstract][Full Text] [Related]
6. Alcohol consumption, finasteride, and prostate cancer risk: results from the Prostate Cancer Prevention Trial.
Gong Z; Kristal AR; Schenk JM; Tangen CM; Goodman PJ; Thompson IM
Cancer; 2009 Aug; 115(16):3661-9. PubMed ID: 19598210
[TBL] [Abstract][Full Text] [Related]
7. Reducing the risk of benign prostatic hyperplasia progression.
Roehrborn CG
Rev Urol; 2002; 4 Suppl 5(Suppl 5):S29-38. PubMed ID: 16986063
[TBL] [Abstract][Full Text] [Related]
8. Smoking and acute urinary retention: the Olmsted County study of urinary symptoms and health status among men.
Sarma AV; Jacobson DJ; St Sauver JL; Lieber MM; Girman CJ; Nehra A; Jacobsen SJ
Prostate; 2009 May; 69(7):699-705. PubMed ID: 19152343
[TBL] [Abstract][Full Text] [Related]
9. Maculopapular Drug Eruption Caused by Finasteride: A Case Report.
Jia H; Ran L
Clin Cosmet Investig Dermatol; 2023; 16():3359-3361. PubMed ID: 38021434
[TBL] [Abstract][Full Text] [Related]
10. Comment on "The post-finasteride syndrome: possible etiological mechanisms and symptoms".
Perelman MA
Int J Impot Res; 2024 Apr; ():. PubMed ID: 38609544
[No Abstract] [Full Text] [Related]
11. Finasteride drug safety alert.
Drug Ther Bull; 2017 Aug; ():. PubMed ID: 28768691
[No Abstract] [Full Text] [Related]
12. Long-term effects of finasteride in patients with benign prostatic hyperplasia: a double-blind, placebo-controlled, multicenter study. PROWESS Study Group.
Marberger MJ
Urology; 1998 May; 51(5):677-86. PubMed ID: 9610579
[TBL] [Abstract][Full Text] [Related]
13. Treatment with finasteride preserves usefulness of prostate-specific antigen in the detection of prostate cancer: results of a randomized, double-blind, placebo-controlled clinical trial. PLESS Study Group. Proscar Long-term Efficacy and Safety Study.
Andriole GL; Guess HA; Epstein JI; Wise H; Kadmon D; Crawford ED; Hudson P; Jackson CL; Romas NA; Patterson L; Cook TJ; Waldstreicher J
Urology; 1998 Aug; 52(2):195-201; discussion 201-2. PubMed ID: 9697781
[TBL] [Abstract][Full Text] [Related]
14. The World Health Organization/International Society of Urological Pathology consensus classification of urothelial (transitional cell) neoplasms of the urinary bladder. Bladder Consensus Conference Committee.
Epstein JI; Amin MB; Reuter VR; Mostofi FK
Am J Surg Pathol; 1998 Dec; 22(12):1435-48. PubMed ID: 9850170
[TBL] [Abstract][Full Text] [Related]
15. Unpublished research from a medical specialty meeting: why investigators fail to publish.
Weber EJ; Callaham ML; Wears RL; Barton C; Young G
JAMA; 1998 Jul; 280(3):257-9. PubMed ID: 9676674
[TBL] [Abstract][Full Text] [Related]
16. Phase III multicenter placebo-controlled study of tamsulosin in benign prostatic hyperplasia. Tamsulosin Investigator Group.
Lepor H
Urology; 1998 Jun; 51(6):892-900. PubMed ID: 9609623
[TBL] [Abstract][Full Text] [Related]
17. Finasteride to prevent morbidity from benign prostatic hyperplasia.
Wasson JH
N Engl J Med; 1998 Feb; 338(9):612-3. PubMed ID: 9475770
[No Abstract] [Full Text] [Related]
18. The Effects of Caloric Restriction on Inflammatory Targets in the Prostates of Aged Rats.
Rago V; Conforti F; La Russa D; Antonucci G; Urlandini L; Lofaro D; Bossio S; Mandalà M; Pellegrino D; Aversa A; Di Agostino S; Perri A
Int J Mol Sci; 2024 May; 25(10):. PubMed ID: 38791274
[TBL] [Abstract][Full Text] [Related]
19. Effects of Taraxaci Herba (Dandelion) on Testosterone Propionate-Induced Benign Prostatic Hyperplasia in Rats.
Lee SM; Lee SM; Song J
Nutrients; 2024 Apr; 16(8):. PubMed ID: 38674879
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
